NEVVI Medicare utilization intelligence

← back

HOBDAY, TIMOTHYM.D. NPI 1316919962 Clinician

Medical Oncology · ROCHESTER, MN

Specialty Medical Oncology — from billed Medicare claims
Trained MAYO MEDICAL SCHOOL — medical school, self-reported to CMS
In practice about 32 years since medical school (class of 1994, self-reported to CMS)
Location ROCHESTER, MN · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 36 codes billed · 33,894 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20192026
MAYO CLINIC
2019–2026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2020-08

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Unlock to see the figure.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J9271 Injection, pembrolizumab, 1 mg
J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj
J1453 Injection, fosaprepitant, 1 mg
J9267 Injection, paclitaxel, 1 mg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J9305 Injection, pemetrexed, not otherwise specified, 10 mg
Q5115 Injection, rituximab-abbs, biosimilar, (truxima), 10 mg
J9041 Injection, bortezomib, 0.1 mg
J2469 Injection, palonosetron hcl, 25 mcg
J2405 Injection, ondansetron hydrochloride, per 1 mg
96375 Injection of additional new drug or substance into vein
J9045 Injection, carboplatin, 50 mg
96413 Administration of chemotherapy into vein, 1 hour or less
J9190 Injection, fluorouracil, 500 mg
J9201 Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
96415 Administration of chemotherapy into vein, each additional hour
96417 Administration of additional new drug or substance into vein, 1 hour or less
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
J9217 Leuprolide acetate (for depot suspension), 7.5 mg
J1200 Injection, diphenhydramine hcl, up to 50 mg
J3489 Injection, zoledronic acid, 1 mg
J3490 Unclassified drugs
J0640 Injection, leucovorin calcium, per 50 mg
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
96372 Injection of drug or substance under skin or into muscle
96411 Administration of additional new drug or substance into vein using push technique
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
96361 Infusion into a vein for hydration, each additional hour
G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l
J7030 Infusion, normal saline solution , 1000 cc
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit)
96409 Administration of chemotherapy into vein using push technique
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.